Importance of NAD+ anabolism in metabolic, cardiovascular and neurodegenerative disorders
Because of these benefits, healthcare providers are increasingly recommending these medications earlier in treatment plans
[6] Preclinical studies in animal models suggest that GLP-1 receptor activation may: Promote neuroplasticity and neurogenesis (formation of new neurons) in the hippocampus, a region often showing reduced volume in depression Modulate neurotransmitter systems , particularly dopamine and serotonin pathways involved in mood regulation and reward processing Reduce neuroinflammation , which is increasingly recognised as contributing to depressive disorders Enhance brain-derived neurotrophic factor (BDNF) expression, a protein crucial for neuronal health and resilience Metabolic improvements associated with GLP-1 therapy may also contribute indirectly to mood benefits
Klinic offers a telehealth platform, making it convenient to consult with experts and access treatment quickly
[DOI] [PubMed] [Google Scholar] 5.Jorsal A., Kistorp C., Holmager P., Tougaard R.S., Nielsen R., Hanselmann A., et al
Labs and InBody are repeated to verify the protocol is producing the expected change before continuing